Stay updated with breaking news from Aml. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gilead Discontinues Phase 3 ENHANCE-3 Trial of Magrolimab Plus Venetoclax/Azacitidine in AML

The phase 3 ENHANCE-3 study of magrolimab plus venetoclax/azacitidine vs venetoclax/azacitidine in select patients with AML has been terminated. ....

Merdad-parsey , Gilead-sciences-inc , World-health-organization , Gilead-sciences , Aml , Acute-myeloid-leukemia , Venclexta , Vidaza , Azacitidine , Venetoclax , Phase-3-enhance-study-nct04313881- , Agrolimab-

Aston Martin Lagonda Global (LON:AML) Sets New 52-Week Low at $170.00

Aston Martin Lagonda Global Holdings plc (LON:AML – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 170 ($2.13) and last traded at GBX 172.61 ($2.16), with a volume of 74751 shares. The stock had previously closed at GBX 174 ($2.18). […] ....

Aston-martin-lagonda , Aston-martin-lagonda-global-holdings , Get-free-report , Martin-lagonda-global-holdings , Aston-martin-lagonda-global-daily , Aston-martin-lagonda-global , Lon-aml , Aml , Consumer-cyclical , Stocks , Technicals ,

Increased Fatigue Associated With Greater Risk of Mortality Among Patients With AML, ALL, MDS

The findings suggest patient-reported outcomes namely fatigue may be helpful in identifying patients at a higher risk of death and other adverse outcomes but warrant further research. ....

United-states , American , National-cancer-institute , University-of-pennsylvania , American-society-of-hematology-annual-meeting , Abramson-cancer-center , Hematology-annual-meeting , Common-terminology-criteria , Adverse-events , All , Aml